arginine has been researched along with Activated Protein C Resistance in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadauke, S; Khor, B; Van Cott, EM | 1 |
| Shaikh, S; Van Cott, EM | 1 |
| Dahlbäck, B | 2 |
| Dorion, RP; Gilbert, C; Klayman, M; Murdock, JD; Stammers, AH; Trowbridge, C; Woods, E; Yen, B | 1 |
| Adamzik, M; Frey, UH; Lehmann, N; Peters, J; Riemann, K; Siffert, W; Sixt, S | 1 |
| Brandslund, I; Dahler-Eriksen, BS; Larsen, TB; Lassen, JF; Petersen, PH | 1 |
| Chi, HS; Kim, SB; Kim, SH; Kim, SW; Kim, TW; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Seo, EJ; Suh, C | 1 |
2 review(s) available for arginine and Activated Protein C Resistance
| Article | Year |
|---|---|
The discovery of activated protein C resistance.
Topics: Activated Protein C Resistance; Arginine; Factor V; Humans; Pedigree; Point Mutation; Protein C; Risk Factors; Thrombophilia; Thrombosis | 2003 |
Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
Topics: Activated Protein C Resistance; Arginine; Factor V; Glutamine; Humans; Point Mutation; Thrombophilia; Thrombosis | 1999 |
1 trial(s) available for arginine and Activated Protein C Resistance
| Article | Year |
|---|---|
The effect of argatroban on activated protein C resistance.
Topics: Activated Protein C Resistance; Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Blood Coagulation; Female; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides | 2009 |
5 other study(ies) available for arginine and Activated Protein C Resistance
| Article | Year |
|---|---|
Activated protein C resistance testing for factor V Leiden.
Topics: Activated Protein C Resistance; Adult; Antithrombins; Arginine; Benzimidazoles; beta-Alanine; Biological Assay; Blood Coagulation Tests; Child; Dabigatran; Factor V; Factor Xa; False Positive Reactions; Female; Hirudins; Humans; Lupus Coagulation Inhibitor; Morpholines; Peptide Fragments; Pipecolic Acids; Pregnancy; Protein C; Recombinant Proteins; Rivaroxaban; Sulfonamides; Thiophenes; Warfarin | 2014 |
Coagulation management of a patient with factor V Leiden mutation, lupus anticoagulant, and activated protein C resistance: a case report.
Topics: Activated Protein C Resistance; Adult; Anticoagulants; Arginine; Coronary Stenosis; Factor V; Female; Heparin, Low-Molecular-Weight; Humans; Intraoperative Care; Lupus Coagulation Inhibitor; Pipecolic Acids; Postoperative Care; Sulfonamides; Thrombocytopenia | 2005 |
Factor V Leiden mutation is associated with improved 30-day survival in patients with acute respiratory distress syndrome.
Topics: Activated Protein C Resistance; Adult; APACHE; Arginine; Cohort Studies; Factor V; Female; Genotype; Glutamine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Point Mutation; Polymorphism, Single Nucleotide; Respiratory Distress Syndrome; Retrospective Studies | 2008 |
Effect of anticoagulant therapy on the hypercoagulable state in patients carrying the factor V Arg506Gln mutation.
Topics: Activated Protein C Resistance; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Case-Control Studies; Factor V; Female; Glycine; Humans; Immunoenzyme Techniques; Linear Models; Male; Middle Aged; Phenprocoumon; Point Mutation; Polymerase Chain Reaction; Statistics, Nonparametric; Warfarin | 1998 |
Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
Topics: Activated Protein C Resistance; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Arginine; Factor V; Glutamine; Humans; Korea; Middle Aged; Point Mutation; Prevalence; Venous Thrombosis | 1998 |